Sunday, April 25, 2010
VIRGO Consortium will receive € 4 million from NGI for a VIRGO-II project, another € 4 million will be contributed by the VIRGO partners. This project aims to generate novel intervention strategies for virus infections on the basis of a detailed understanding of the virus–host interaction at the molecular level.
The consortium focuses on respiratory virus, hepatitis virus and HIV infections. There is a large unmet medical need for effective and safe diagnostic, prophylactic, prognostic and therapeutic strategies and tools for these infections that continue to cause a significant burden on (public) health and society. VIRGO also received a FES grant of € 10.7 million.